🇺🇸 FDA
Patent

US 9234198

Multiple exon skipping compositions for DMD

granted A61PA61P21/00A61P21/04

Quick answer

US patent 9234198 (Multiple exon skipping compositions for DMD) held by Sarepta Therapeutics, Inc. expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P21/00, A61P21/04